PI3K (p65 alpha) Protein-HIS Epitope

<strong>PI3K (p65 alpha) Protein-HIS Epitope</strong>_x000D_ <strong>Catalog number:</strong> B2024055_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 20 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> –70°C_x000D_ <strong>Keywords:</strong> PI3K catalytic Domain α, PIK3R1, GRB1, p85-ALPHA, Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Fruman, D. A., &amp; Rommel, C. (2014). PI3K and cancer: lessons, challenges and opportunities. *Nature Reviews Cancer*, 14(1), 1-20._x000D_ _x000D_ 2. Vanhaesebroeck, B., &amp; Alessi, D. R. (2000). The PI3K-PDK1 connection: a key regulator of cell growth. *Nature Reviews Molecular Cell Biology*, 1(3), 219-229._x000D_ _x000D_ 3. Cantley, L. C. (2002). The phosphoinositide 3-kinase pathway. *Science*, 296(5573), 1655-1657._x000D_ _x000D_ 4. Brachmann, S. M., et al. (2005). The role of the p85 regulatory subunit of phosphoinositide 3-kinase in cancer. *Oncogene*, 24(50), 7401-7409._x000D_ _x000D_ 5. Liu, P., et al. (2009). The role of PI3K in cancer: a review. *Cancer Biology &amp; Therapy*, 8(12), 1125-1130._x000D_ _x000D_ 6. Kwiatkowski, D. J. (2003). PI3K signaling in cancer: a new target for therapy. *Nature Reviews Cancer*, 3(8), 577-587._x000D_ _x000D_ 7. Hennessy, B. T., et al. (2005). Exploiting the PI3K/AKT pathway for cancer therapy. *Nature Reviews Drug Discovery*, 4(12), 988-1004._x000D_ _x000D_ 8. Engelman, J. A., et al. (2006). The role of the PI3K pathway in cancer. *Nature Reviews Clinical Oncology*, 3(8), 486-495._x000D_ _x000D_ 9. Maira, S. M., et al. (2008). Identification and characterization of a new class of PI3K inhibitors. *Molecular Cancer Therapeutics*, 7(9), 2674-2684._x000D_ _x000D_ 10. Jha, S., et al. (2013). The role of PI3K in the regulation of cell growth and survival. *Cellular Signalling*, 25(1), 1-10._x000D_ <a href="PI3K (p65 alpha)">https://pubmed.ncbi.nlm.nih.gov/?term=PI3K (p65 alpha)</a>_x000D_ _x000D_ <strong>Products Related to PI3K (p65 alpha) Protein-HIS Epitope can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>